Bigul

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

This is in reference to the 'Press Release' submitted with your good office, we would like to mention that, inadvertently, the financial year was mentioned as 'FY 2020-22' instead of 'FY 2021-22'. All other information remains unchanged. The revised press release is enclosed herewith.
27-07-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation

Please find enclosed the Investors Presentation (Q1'FY22) July, 2021, based on the financial performance of the Company for the quarter ended 30th June, 2021.
27-07-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed press release on the financial performance of the Company for the quarter ended 30th June, 2021 with the title - 'Morepen records Highest ever Quarterly Revenue Growth of 50% Medical Devices Sales shoot up by 189%; Profit Before Tax doubles Quarter on Quarter'.
27-07-2021
Bigul

Morepen Laboratories Ltd - 500288 - Results-Financial Results For June 30, 2021

This is to inform you that the Board of Directors of the Company, in their meeting held on Tuesday, 27th July, 2021 (commenced at 09:30 AM and concluded at 11:30 AM), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter ended 30th June, 2021 is enclosed herewith.
27-07-2021
Bigul

Morepen Laboratories Ltd - 500288 - Outcome Of The Meeting Of Board Of Directors Of The Company Held On July 27, 2021

This is to inform you that the Board of Directors of the Company, in their meeting held on Tuesday, 27th July, 2021 (commenced at 09:30 AM and concluded at 11:30 AM), have, inter-alia, considered and approved the unaudited standalone and consolidated financial results of the Company for the quarter ended 30th June, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' along-with the 'Limited Review Report' of the Auditors of the Company for the quarter ended 30th June, 2021 is enclosed herewith.
27-07-2021
Bigul

Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that subsequent to the declaration of unaudited standalone and consolidated financial results for the quarter ended 30th June, 2021, the Company is organizing an 'Analyst/ Investor Conference Call' on Tuesday, 27th July, 2021 at 04:00 P.M. (IST).
26-07-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 21st July, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificates of the Company.
22-07-2021
Bigul

Morepen Laboratories Ltd - 500288 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2021

MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter ended June 30, 2021
20-07-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 17th July, 2021 and 19th July, 2021, received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificates of the company.
19-07-2021
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Shareholding for the Period Ended June 30, 2021

Morepen Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
17-07-2021
Next Page
Close

Let's Open Free Demat Account